Please login to the form below

Not currently logged in
Email:
Password:

Takeda strengthens leadership team with business unit director

Craig Adkins takes up the position after being at the firm for ten years

Takeda UK has appointed Craig Adkins as its new business unit director for irritable bowel disease (IBD). 

Adkins joins the senior leadership team having spent 18 months in the Zurich office leading many strategic projects across the Europe and Canada region alongside European senior leadership. 

Adkins has almost 20 years of experience working in the pharma industry, with a long history at Takeda having joined in 2005 as a regional account director. 

One of Adkins most notable successes has been the leadership of a successful repatriation, resulting in a doubled market share and growth on a mature brand.  

Commenting on the recent appointment, Yasuhiro Fukutomi, managing director, Takeda UK, says: “We are delighted to have Craig back in the UK and joining the senior leadership team. 

“He brings with him a wealth of invaluable international experience to complement the expertise of our existing senior leadership team and we have no doubt that his experience and ability to lead teams will see him deliver the same success he has achieved in the past.”

Article by
Ben Adams

15th May 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics